NASDAQ: LTGO
Latigo Biotherapeutics Revenue

Latigo Biotherapeutics revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LTGO annual revenue was $0.0, with N/A growth year-over-year.

LTGO revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when LTGO announces revenue.

LTGO Revenue History By Year

LTGO Yearly RevenueLTGO RevenueLTGO ChangeLTGO Revenue Growth
2025-12-31$0.00N/AN/A
2024-12-31$0.00N/AN/A

1 of 1

Latigo Biotherapeutics Revenue FAQ

What was LTGO's revenue last quarter?

Latigo Biotherapeutics (NASDAQ: LTGO) reported Q1 2026 revenue of $0.00 up N/A year over year. In the same quarter last year, Latigo Biotherapeutics's revenue was $0.00.

What was Latigo Biotherapeutics's revenue in 2025?

Latigo Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.

How much does Latigo Biotherapeutics make in a day?

Based on Latigo Biotherapeutics annual revenue for the past one years, LTGO makes an average of $0.00 per day.

What was Latigo Biotherapeutics's annual revenue growth in the past year?

As of Q3 2026, Latigo Biotherapeutics's revenue has grown null year over year. Latigo Biotherapeutics's revenue in the past year totaled N/A.

How much does Latigo Biotherapeutics make in a year?

Latigo Biotherapeutics's revenue by year for the past one years is:
  • Latigo Biotherapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a N/A decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.